Stryker Corporation acquired 50.7% stake in Vexim SA from Truffle Capital, Kreaxi, Bpifrance Participations SA, Vincent Gardès and José Da Gloria for €82.3 million.
October 23, 2017
Share
Stryker Corporation (NYSE:SYK) acquired 50.7% stake in Vexim SA (ENXTPA:ALVXM) from Truffle Capital, Kreaxi, Bpifrance Participations SA, Vincent Gardès and José Da Gloria for €82.3 million on October 24, 2017. Stryker Corporation paid €20 for acquiring 4.1 million shares and €3.91 for 0.17 million BSAAR warrants. In accordance with French tender offer laws and regulations, Stryker will file a simplified cash public offer to purchase all remaining VEXIM shares and BSAAR warrants. BNP Paribas acted as financial advisor and presenting bank and Richard Witzel of Skadden, Arps, Slate, Meagher & Flom LLP acted as legal advisor to Stryker Corporation. Cyrille Perard of Goldman Sachs acted as financial advisor and Charles Cardon, Quentin Durand and Vianney Toulouse of Dechert LLP acted as legal advisor to Vexim.
Stryker Corporation (NYSE:SYK) completed the acquisition of 50.7% stake in Vexim SA (ENXTPA:ALVXM) from Truffle Capital, Kreaxi, Bpifrance Participations SA, Vincent Gardès and José Da Gloria on October 24, 2017.
Stryker Corporation is one of the world's leaders in designing, manufacturing, and selling orthopedic equipments. Net sales break down by family of products as follows:
- surgical equipments and neurotechnology products (57.5%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipments, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment;
- orthopedic implants (42.5%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants.
At the end of 2022, the group had 48 production sites worldwide.
Net sales are distributed geographically as follows: the United States (73.9%), Europe/Middle East/Africa (12.7%), Asia/Pacific (10.2%) and other (3.2%).
Stryker Corporation acquired 50.7% stake in Vexim SA from Truffle Capital, Kreaxi, Bpifrance Participations SA, Vincent Gardès and José Da Gloria for €82.3 million.
STRYKER CORPORATION 
